Introduction and hypothesis Since the first reported laparoscopic sacrocolpopexy in 1991, a limited number of singlecenter studies have attempted to assess the procedure's effectiveness and safety. Therefore, we analyzed a national Medicare database to compare real-world short-term outcomes of open and laparoscopically assisted (including robotic) sacrocolpopexy in a United States sample of patients. Methods Public Use File data for a 5 % random national sample of all Medicare beneficiaries aged 65 and older were obtained from the Centers for Medicare and Medicaid Services for the years 2004-2008. Women with pelvic organ prolapse were identified using ICD-9 diagnosis codes. CPT-4 procedure codes were used to identify women who underwent open (code 57280) or laparoscopic (code 57425) sacrocolpopexy. Individual subjects were followed for 1 year post-operatively. Outcomes measured, using ICD-9 and CPT-4 codes, included medical and surgical complications and reoperation rates.
Introduction
Abdominal sacrocolpopexy (ASC) is considered the gold standard in the surgical management of apical prolapse, with long-term success rates up to 78-100 % and with reported patient satisfaction rates of 85-100 % [1] . Randomized comparative effectiveness trials and systematic literature reviews have demonstrated the anatomical superiority of ASC to vaginal apical suspension procedures [2, 3] . Although it is the most durable operation available to date, the morbidity associated with a laparotomy limits its broad use in women with multiple medical co-morbidities or relative contraindications to the approach.
Laparoscopy offers a minimally invasive, but technically challenging alternative to open sacrocolpopexy. The use of robotic technology has made laparoscopic sacrocolpopexy a feasible procedure for many pelvic surgeons who find the traditional laparoscopic procedure too arduous to perform. The technological advancements associated with the use of a robot contributed to a fast and wide spread of this procedure [4] . Two single-center observational studies, one comparative and the other not, involving a total of 77 patients, suggest comparable effectiveness between open and laparoscopic (including robotic-assisted) sacrocolpopexy with respect to shortterm cure of prolapse, although convalescence has been shown to be shorter in the laparoscopic/robotic group [5, 6] . To date, the one published randomized trial of 47 women, focused on the non-inferiority of laparoscopic sacrocolpopexy compared with open sacrocolpopexy, demonstrated a 15 % recurrence of symptomatic prolapse 1 year post-operatively, with less patient satisfaction reported in the laparoscopic group [7] .
Despite a relative paucity of data, the minimally invasive approach to sacrocolpopexy has become ubiquitous, making recruitment into a randomized trial of open vs laparoscopic colpopexies more difficult. In this study we sought to use a national dataset to compare -year post-operative outcomes between open and laparoscopic (including robotic-assisted) sacrocolpopexies performed outside of a study setting.
Materials and methods
After obtaining an exemption from the University of California, Los Angeles Institutional Review Board, Public Use Files from the Centers for Medicare and Medicaid Services were obtained for a 5 % random national sample of beneficiaries aged 65 and over. A 5 % national random sample is available for public use, and provides numbers of patients adequate to detect meaningful differences between groups. In the United States eligible adults begin to receive Medicare benefits at the age of 65, unless they meet criteria (such as disability) at a younger age. Randomization was achieved using the last two digits of the patient Health Insurance Claim number, which is based on the Social Security Number. International Classification of Disease, 9th edition (ICD-9), codes were used to identify women diagnosed with pelvic organ prolapse (POP), as previously described [8] . Current Procedural Terminology, 4th edition (CPT-4) codes were used to identify women who had undergone either open (code 57280) or laparoscopic (code 57425) sacrocolpopexy in the years 2004 to 2008. Because there was no CPT-4 procedure code for robotic sacrocolpopexy, we made the assumption that the laparoscopic group included robotic approaches. Although 2003 data were available for analysis, there were no laparoscopic sacrocolpopexies in the Medicare database; therefore, analysis began with 2004 data. Because of the relatively small numbers in the laparoscopic arm, data for each of the 5 years was pooled and each subject was followed for 1 year, through 2009. At the time of our analyses 2009 was the most recent year with data available for public use.
Our primary endpoints were perioperative complications and early treatment failure, as demonstrated by reoperation for prolapse. ICD-9 diagnosis codes were used to identify complications. Treatment failure was defined as repeat treatment for prolapse, including pessary placement or repeat prolapse surgery, including obliterative procedures. These procedures were identified by ICD-9 and CPT-4 procedure codes (Appendix, Table 5 ). Patient data obtained included age, race/ethnicity, and co-morbidities as measured by the Charlson co-morbidity index [9] . The Charlson index sums up scores from 19 weighted co-morbidities to predict the likelihood of 1-year mortality for a patient, with a higher score indicating a greater burden of co-morbidity. Frequencies were determined for categorical variables and the Chisquared test was used to detect a statistically significant difference between cohorts. To assess the association between type of surgical procedures and occurrence of complications, time-to-event models using Cox proportional hazard regression were estimated. The failure event was defined as the occurrence of the first repeat treatment for POP. Time to event was assessed as the number of quarters (3-month periods) between the initial surgery and the quarter during which the repeat treatment for POP occurred. A set of pre-specified covariates including demographic characteristics and co-morbidities were included in the regression model. Hazard ratios and 95 % confidence intervals are reported. Separate models were estimated for individual types of adverse events (including bleeding, infection, urinary retention), and for all adverse events combined. To account for potential confounders of urinary retention and mesh-related complications, subset analyses were performed on subjects who underwent concomitant sling and hysterectomy. All analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC, USA), and findings with p values <0.05 were considered statistically significant. (Table 1) . Demographic characteristics are listed in Table 2 . Open and laparoscopic sacrocolpopexy groups differed by race/ethnicity (likely because of a large proportion of unknown race in the laparoscopic group) and geographic region (defined by the US Census Bureau), with the open approach utilized more frequently in the Midwest. The Charlson score of subjects in the open group was significantly higher, indicating more comorbidities in this group. There were no differences in the number of concomitantly performed sling surgeries and hysterectomies between the groups (Table 3) .
Results

In
Perioperative morbidity was greater in the open sacrocolpopexy group owing to a higher rate of medical complications (31.5 % vs 22.7 %, p=0.023) and febrile morbidity (6.0 % vs 1.1 %, p=0.004). A trend toward a higher rate of perioperative pain was noted in the open sacrocolpopexy group. The rates of urinary retention (15.9 % vs 8.0 %, p= 0.006), and urinary tract infections (UTIs; 38.8 % vs 26.7 %, p=0.002) were also greater in the open vs the laparoscopic group (Table 4) . Within the concomitant sling cohort, which had the highest rates of urinary retention, urinary retention remained significantly higher in the open subset (20.8 % vs 2.3 %, p=0.0021). UTIs were also higher in this group (43.4 % vs.20.9 %, p=0.01) possibly because of a collinear relationship with urinary retention and associated elevated post-void residual and/or need for catheterization (data not shown).
At 1-year post-operatively, the number of re-operations for anterior vaginal wall prolapse was significantly higher in the laparoscopic group (3.4 % vs 0.9 %, p<0.02). The rates of reoperation in the posterior compartment or for recurrent apical prolapse were low and did not differ between the groups.
Overall the rate of mesh-related complications did not differ between the groups; however, in the subset of subjects who underwent sacrocolpopexy with concomitant hysterectomy mesh-related complications were significantly higher in the laparoscopic group (5.4 % vs 0 %, p=0.026). All meshrelated complications in this subset occurred in subjects who had a total as opposed to a supracervical hysterectomy. In women who had a sling surgery performed at the time of sacrocolpopexy, 4.7 % underwent a revision of the prosthetic vaginal graft (code 57295) in the laparoscopic group (unknown if due to complications arising from sling or prolapse repair), compared with none in the open group (p=0.02).
Discussion
Our study yielded several important findings. First, we observed a rapid increase in the number of laparoscopic sacrocolpopexies over the years 2004 through 2008, with the most significant increase in 2007 and 2008. These patterns may reflect the introduction of robotic technology into the field of urogynecology; however, the robotic procedure's assistance was not reflected in the CPT-4 procedure codes; therefore, we were unable to separately analyze outcomes of laparoscopic vs robotically assisted laparoscopic sacrocolpopexies.
Because data on prolapse stage or degree of symptoms are not available in the claims database, we relied on repeat prolapse operations (based on CPT-4 procedure codes) as a surrogate for symptomatic recurrence. The overall reoperation rate at 1-year post-operatively was low in both groups. However, the laparoscopic approach resulted in a significantly higher rate of reoperation for anterior compartment prolapse than the open sacrocolpopexy. Unfortunately, the only published RCT of laparoscopic vs open sacrocolpopexy did not report postoperative objective measures of the anterior compartment [7] . The reoperation rate in our study was higher than the 1.8 % rate in a recent trial, comparing laparoscopic sacrocolpopexy with transvaginal mesh procedures for vaginal vault prolapse [10] . However, our findings are consistent with previously published studies that have shown higher rates of prolapse recurrence after laparoscopic sacrocolpopexies vs open [11] [12] [13] . This is possibly due to technical difficulties of distal anterior dissection with the laparoscopic approach, but studies specifically comparing the extent of dissection in the vesicovaginal plane in open vs laparoscopic sacrocolpopexies are necessary to explore this possibility. Robotic assistance may have the potential for better anterior vaginal dissection and more distal placement of mesh; however, recent RCTs comparing laparoscopic with robotic sacrocolpopexy performed for vaginal vault prolapse did not identify any differences in anatomical outcomes or quality-of-life measures between the groups at 1 year post-operatively [14, 15] . A higher overall perioperative complication rate in the open sacrocolpopexy group is likely a reflection of a greater baseline level of co-morbidities in this group. Despite reports of longer operative times with the laparoscopic approach [5] , our data showed an increased rate of cardiopulmonary complications with the open approach. As surgeons become more comfortable with the technical aspects of laparoscopic sacrocolpopexies as well as robotically assisted procedures, we expect these minimally invasive approaches to dominate in patients with higher levels of co-morbidities. As might be expected, perioperative pain was greater in the open group, but the difference did not reach statistical significance. A higher rate of urinary retention occurred in women who underwent slings concomitantly with open as opposed to laparoscopic sacrocolpopexies. This is possibly due to open procedures causing more post-operative pain and therefore a delay in the return of the voiding function. The increased rate of UTIs in this same subset is likely attributable to the urinary retention and associated need for catheterization.
The overall rate of mesh-related complications was low and there were no differences between the groups at 1-year followup. However, mesh-related complications were significantly higher in the laparoscopic group in the subset of women who underwent a concomitant total hysterectomy. Our findings that supracervical hysterectomy is protective from mesh exposure is consistent with a recently published study by TanKim et al., which reports a significantly higher rate of vaginal mesh exposure in cases of total vs supracervical hysterectomies performed at the time of sacrocolpopexies [16] .
The strength of our study lies in the advantages of using national US data, which allow for analysis of a large representative sample of patients with a broad geographic distribution. These observational real world data are particularly valuable given the absence of level I evidence in the literature. The limitations of our research are inherent to the analysis of claims data. The accuracy of data is dependent on the proper coding by health care providers, and pertinent clinical details not reflected in the ICD-9 and/or CPT-4 codes are not available. Specifically, we could not compare outcomes between robotic and laparoscopic groups. We also did not differentiate by hysterectomy types (laparoscopically assisted vaginal hysterectomy vs purely laparoscopic hysterectomy). Despite these limitations, the use of the Medicare data files have proven valuable in understanding clinical practice patterns and real world outcomes [17, 18] .
Laparoscopic sacrocolpopexy is an important addition to the armamentarium of the reconstructive procedures for pelvic organ prolapse. However, this procedure should not be presumed to be analogous to the open sacrocolpopexy. Our findings support a great need to vigilantly follow outcomes of this, now ubiquitous, approach to prolapse repair. 
